Adcock Ingram gives up on Cipla Medpro

Adcock Ingram abandoned a takeover of Cipla Medpro South Africa after discovering that India's Cipla may cancel a supply agreement with its smaller rival, casting doubt over the merits of the bid. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.